Shortage Status

Status

Date Posted

Date Posted (dd-mm-yyyy)

  • CIPLA LENALIDOMIDE lenalidomide 25 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024

  • MAYZENT siponimod 0.25 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 May 2025
    View Detail

  • OLANZAPINE ODT GENERICHEALTH 10 olanzapine 10 mg

    Availability: Unavailable Deletion from market: 31 Jul 2024

  • LUKAIR montelukast (as sodium) 10 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Apr 2026
    View Detail

  • DBL BORTEZOMIB 2.5 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Oct 2024

  • DBL Bortezomib bortezomib 1.0 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Oct 2024

  • Pfizer (Australia) VINCRISTINE SULFATE 2mg/2mL

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 May 2025
    View Detail

  • DIAFORMIN XR metformin hydrochloride 500mg

    Availability: Unavailable Deletion from market: 20 Aug 2024

  • PERINDO 2 perindopril erbumine 2mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Sep 2024

  • PERINDO 4 perindopril erbumine 4mg

    Availability: Unavailable Deletion from market: 28 Feb 2025
    View Detail

  • PERINDO 8 perindopril erbumine 8mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 28 Feb 2025
    View Detail

  • MIXTARD 30/70 PENFILL human insulin (rys) 100IU/mL injection multidose cartridge

    Availability: Unavailable Deletion from market: 02 Oct 2024